Biotech

All Articles

OS Treatments refiles $6M IPO to cash HER2 medication, preclinical ADCs

.Operating system Therapies are going to detail on the NYSE American stock exchange this morning by ...

ALX's waning CD47 reaction cost sends sell spiraling down

.ALX Oncology's period 2 stomach cancer reaction price has actually weakened. After finding its own ...

Ionis centers eye health condition from intendeds of Roche-partnered possibility after information disappoint

.An Additional of Ionis Pharmaceuticals' vital midphase readouts has fallen short of expectations, c...

Biogen's chief executive officer mentioned no unsafe handle 2023. He prepares to be vibrant

.While Biogen's pharma peers are actually hunting for late-stage assets along with little risk, CEO ...

Instil refills pipe in $2B biobucks handle ImmunOnco

.Instil Biography has actually been actually a biotech seeking a pipeline after it scrapped its lead...

Biogen ignores Denali Alzheimer's collab

.Biogen has actually restored liberties to a very early Alzheimer's health condition system to Denal...

Takeda taps brand new head of US oncology service-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as...

Vertex, hammered by AATD again, falls 2 properties on throw away stack

.Vertex's effort to deal with a rare hereditary ailment has attacked an additional problem. The biot...

Vir increases 3 T-cell engagers from Sanofi, gives up 25% of staff

.Vir Medical's second-quarter incomes report had not been except huge updates. The company invited a...

Galapagos pauses CAR-T tissue therapy trial over Parkinsonism instance

.Galapagos has paused enrollment in a trial of a BCMA-directed CAR-T tissue therapy, pushing the bra...